SwingTrade Member Forum

[umiak]

Here is the condensed story from AS on KTOV dilution, when warrants are included the recent offering is at about $1.71:

Thinly traded nano cap Kitov Pharmaceuticals (KTOV -5.3%) eases on more than double normal volume in response to its announcement of the pricing of its follow-on equity offering.

The company has priced its public offering of 2,378,823 Class A units at $3.40 per unit and 1,150,589 Class B units also at $3.40.

Each Class A unit consists of one American Depositary Share (ADS) and a listed warrant (symbol: KTOVW") to purchase one ADS at $3.78. Each ADS equals 20 ordinary shares of Kitov. The listed warrants will expire on November 25, 2020.

Each Class B unit consists of one non-listed pre-funded warrant to purchase one ADS and one listed warrant to purchase one ADS. The non-listed warrants will be exercisable for 10 years from the date of issuance at an exercise price of $0.01 per ADS.Gross proceeds will be ~$12M. Net proceeds will fund the potential acquisition of new product candidates and working capital.

Are the underwriters running the show? No position